Other studies report no difference in serum ACE and ACE2 concentrations between patients with COVID-19 compared with matched controls [75], while studies find that patients admitted with COVID-19 display lower ACE and no change in ACE2 activity [76]. The gene discussed is ACE; the disease is COVID-19.